Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • Log out
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Rapid CommunicationAccelerated Communication

5-Iodo-A-85380, an α4β2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors

Alexey G. Mukhin, Daniela Gündisch, Andrew G. Horti, Andrei O. Koren, Gilles Tamagnan, Alane S. Kimes, Joann Chambers, D. Bruce Vaupel, Sarah L. King, Marina R. Picciotto, Robert B. Innis and Edythe D. London
Molecular Pharmacology March 2000, 57 (3) 642-649; DOI: https://doi.org/10.1124/mol.57.3.642
Alexey G. Mukhin
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela Gündisch
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew G. Horti
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei O. Koren
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Tamagnan
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alane S. Kimes
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joann Chambers
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Bruce Vaupel
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah L. King
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marina R. Picciotto
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert B. Innis
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edythe D. London
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

In an effort to develop selective radioligands for in vivo imaging of neuronal nicotinic acetylcholine receptors (nAChRs), we synthesized 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine (5-iodo-A-85380) and labeled it with 125I and123I. Here we present the results of experiments characterizing this radioiodinated ligand in vitro. The affinity of 5-[125I]iodo-A-85380 for α4β2 nAChRs in rat and human brain is defined by K d values of 10 and 12 pM, respectively, similar to that of epibatidine (8 pM). In contrast to epibatidine, however, 5-iodo-A-85380 is more selective in binding to the α4β2 subtype than to other nAChR subtypes. In rat adrenal glands, 5-iodo-A-85380 binds to nAChRs containing α3 and β4 subunits with 1/1000th the affinity of epibatidine, and exhibits 1/60th and 1/190th the affinity of epibatidine at α7 and muscle-type nAChRs, respectively. Moreover, unlike epibatidine and cytisine, 5-[125I]iodo-A-85380 shows no binding in any brain regions in mice homozygous for a mutation in the β2 subunit of nAChRs. Binding of 5-[125I]iodo-A-85380 in rat brain is reversible, and is characterized by high specificity and a slow rate of dissociation of the receptor–ligand complex (t 1/2 for dissociation ∼2 h). These properties, along with other features observed previously in in vivo experiments (low toxicity, rapid penetration of the blood-brain barrier, and a high ratio of specific to nonspecific binding), suggest that this compound, labeled with 125I or 123I, is superior to other radioligands available for in vitro and in vivo studies of α4β2 nAChRs, respectively.

Footnotes

    • Received September 29, 1999.
    • Accepted December 10, 1999.
  • Send reprint requests to: Edythe D. London, Brain Imaging Center, National Institute on Drug Abuse, 5500 Nathan Shock Dr., Baltimore, MD 21224. E-mail: elondon{at}tracer.org

  • ↵1 A preliminary report of this work has been presented previously (Mukhin AG, Gündisch D, Horti AG, Koren AO, Kimes AS, Vaupel DB and London ED (1998) 5-Iodo-A-85380–a novel highly selective ligand for the α4β2 subtype of nicotinic acetylcholine receptors.Soc Neurosci Abstr 24:85).

  • The research described in this publication was supported by the Intramural Research Program of the National Institute on Drug Abuse, funding from the Office of the National Drug Control Policy, and funding from Department of Veterans Affairs (Connecticut/Massachusetts VA Mental Illness Research, Education, and Clinical Center). Samples of postmortem brain tissue were obtained from the Brain and Tissue Bank for Developmental Disorders under National Institutes of Health Contract no. NO1-HD-1–3138.

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 57 (3)
Molecular Pharmacology
Vol. 57, Issue 3
1 Mar 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
5-Iodo-A-85380, an α4β2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationAccelerated Communication

5-Iodo-A-85380, an α4β2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors

Alexey G. Mukhin, Daniela Gündisch, Andrew G. Horti, Andrei O. Koren, Gilles Tamagnan, Alane S. Kimes, Joann Chambers, D. Bruce Vaupel, Sarah L. King, Marina R. Picciotto, Robert B. Innis and Edythe D. London
Molecular Pharmacology March 1, 2000, 57 (3) 642-649; DOI: https://doi.org/10.1124/mol.57.3.642

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Rapid CommunicationAccelerated Communication

5-Iodo-A-85380, an α4β2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors

Alexey G. Mukhin, Daniela Gündisch, Andrew G. Horti, Andrei O. Koren, Gilles Tamagnan, Alane S. Kimes, Joann Chambers, D. Bruce Vaupel, Sarah L. King, Marina R. Picciotto, Robert B. Innis and Edythe D. London
Molecular Pharmacology March 1, 2000, 57 (3) 642-649; DOI: https://doi.org/10.1124/mol.57.3.642
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • GABAA Receptor Desensitization by Low GABA
  • Structure of the Diltiazem Receptor Site on Calcium Channels
  • 5-HT and Sleep
Show more Accelerated Communication

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics